Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: The Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic study

Scott D. Solomon, Hicham Skali, Mikhail Bourgoun, James Fang, Jalal K. Ghali, Michel Martelet, Dariusz Wojciechowski, Baiba Ansmite, Janis Skards, Toivo Laks, David Henry, Milton Packer, Marc A. Pfeffer

Clinical Sciences

Research output: Contribution to journal › Article › peer-review

42 Scopus citations

Fingerprint

Dive into the research topics of 'Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: The Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic study'. Together they form a unique fingerprint.

Sort by
Weight
Alphabetically

Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: The Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic study

Fingerprint

Medicine & Life Sciences